Probable Novel APP Met671Leu Mutation in a Chinese Han Family with Early-Onset Alzheimer’s Disease
Author:
Ma Limin1, Wang Fengyu1, Chen Shuai1, Wang Shenghui1, Wang Zhenzhen1, Xia Mingrong1, Li Yongli1, Ma Huimin1, Zhang Jiewen1, Shang Junkui1
Affiliation:
1. Henan Provincial People's Hospital
Abstract
Abstract
Familial Alzheimer’s disease (AD) is a rare disease caused by autosomal-dominant mutations. APP (encoding amyloid precursor protein), PSEN1 (encoding presenilin 1), and PSEN2 (encoding presenilin 2) are the most common genes cause dominant inherited AD. This study aimed to demonstrate a Chinese early-onset AD pedigree presenting as progressive memory impairment, apraxia, visual-spatial disorders, psychobehavioral disorders, and personality changes with a novel APP gene mutation. The family contains four patients, three carries and three normal family members. The proband underwent brain magnetic resonance imaging (MRI),18F-fludeoxyglucose positron emission tomography (18F-FDG-PET), cerebrospinal fluid amyloid detection, 18F-florbetapir (AV-45) Positron Emission Computed Tomography (PET) imaging, whole-exome sequencing and Sanger sequencing. Brain MRI images showed brain atrophy, especially in the entorhinal cortex, temporal hippocampus, and lateral ventricle dilation. The FDG-PET showed hypometabolism in the frontotemporal, parietal, and hippocampal regions. 18F-florbetapir (AV-45) PET imaging showed cerebral cortex Aβ protein deposition. The cerebrospinal fluid amyloid protein test showed Aβ42/Aβ40 ratio decreases, pathological phosphor-tau level increases. Whole-exome sequencing detected a new missense mutation of codon 671 (M671L), which was a heterozygous A to T point mutation at position 2011 (c.2011A > T) in exon 16 of the amyloid precursor protein, resulting in the replacement of methionine to Leucine. The co-separation analysis was validated in this family. The mutation was found in 3 patients, 3 clinical normal members in the family, but not in the other 3 unaffected family members, 100 unrelated normal subjects, or 100 sporadic patients with AD. This mutation was probably pathogenic and novel in a Chinese Han family with early-onset AD.
Publisher
Research Square Platform LLC
Reference23 articles.
1. Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and Management of Dementia: Review. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review]. JAMA, 322(16), 1589–1599. doi: 10.1001/jama.2019.4782 2. Ayodele, T., Rogaeva, E., Kurup, J. T., Beecham, G., & Reitz, C. (2021). Early-Onset Alzheimer's Disease: What Is Missing in Research? [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review]. Curr Neurol Neurosci Rep, 21(2), 4. doi: 10.1007/s11910-020-01090-y 3. Ben, K. N., Tyteca, D., Marinangeli, C., Depuydt, M., Collet, J. F., Courtoy, P. J.,... Kienlen-Campard, P. (2012). Structural features of the KPI domain control APP dimerization, trafficking, and processing. [Journal Article; Research Support, Non-U.S. Gov't]. FASEB J, 26(2), 855–867. doi: 10.1096/fj.11-190207 4. Bolos, M., Hu, Y., Young, K. M., Foa, L., & Small, D. H. (2014). Neurogenin 2 mediates amyloid-beta precursor protein-stimulated neurogenesis. [Journal Article; Research Support, Non-U.S. Gov't]. J Biol Chem, 289(45), 31253–31261. doi: 10.1074/jbc.M114.581918 5. Chetelat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S.,... Drzezga, A. (2020). Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. [Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review]. Lancet Neurol, 19(11), 951–962. doi: 10.1016/S1474-4422(20)30314-8
|
|